Headline Details

Hitting cancer early: AstraZeneca's bid to outmaneuver rivals

Published on: Fri, 06 Jul 2018 7:28:16 UTC
News Agency: Reuters
Description:
AstraZeneca suffered its biggest daily share price drop a year ago after a key cancer drug trial failed amid feverish speculation the chief executive might quit.

Click here for FULL Story on Reuters

Also happening now

HeadlineNews Agency
Widespread blackout hits Venezuela, first major outage since March Reuters
Rocket fired from inside Syria wounds five in Turkish border town: governor Reuters
Libya's Mitiga airport halts air traffic after air strike: statement Reuters
Iran warns West against starting conflict, says not looking for confrontation Reuters
Greece's newly-elected government wins confidence vote on economic policy Reuters